Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)

Clinical trial NCT07346859 · RECRUITING

Trial details

NCT number: NCT07346859
Sponsor: Biopharma Plasma LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Diseases

Start date: 2025-12-17
Primary completion: 2028-04-17
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.